Latest news
GI Cancer Cases, Deaths Projected to Nearly Double by 2050 - Cedars-SinaiCedars-Sinai · Tue, 04 Aug 2026 02:58:05 GMTSonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMT